EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells.

Onco Targets Ther · 2019 · PMC6680222 · PMID 31534346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

Signaling via p-ERK1/2 seems to be less relevant as no significant changes, but only a small trend to induced p-ERK1/2 levels could be shown.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.